AI tool
DeviceBoth the arms will undergo the use of "AI tool" developed in the group. The tool will be trained to detect outcomes.
NCT Number: NCT06469606
Mammography is the most common method for breast imaging, and it provides information for model building and analysis. Radiomics applied to mammography has the potential to revolutionize clinical decision-making by providing valuable insights into risk assessment and disease detection. Despite this, the influence of imaging parameters and clinical and biological factors on radiological texture features remains poorly understood. There is a pressing need to overcome the obstacle of system-inherent effects on mammographic images to facilitate the translation of radiological texture features into routine clinical practice by enabling reliable and robust AI-based or AI-aided decision-making. Furthermore, understanding the relationship between imaging parameters, textural features, and clinical and biological information supports the clinical use of AI. The objective of this study is to evaluate AI methods for clinical practice and to study how it relates to clinical factors and biological features.
Trial opening soon.
Get Notified18 year and older
Female
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Both the arms will undergo the use of "AI tool" developed in the group. The tool will be trained to detect outcomes.
Time frame: Through study completion, an average of 5 year
Aim: to evaluate how imaging parameters affect the mammographic texture features
Time frame: through study completion, an average of 10 year
Aim: To evaluate whether there is an interplay between mammographic texture feature parameters and pathological and biological features (e.g., breast cancer biomarkers)
Contact information is provided by the study sponsor or research team.
Tampere University Hospital
Other
A Cohort Study on feMale Patients' mammogRaphic texturE featureS: the COMPRESS Trial
Acronym: COMPRESS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06510738
Artificial Intelligence, Breast Cancer
View Trial DetailsNCT04009278
Breast Cancer, Breast Diseases
Reggio Emilia, RE, Italy
View Trial DetailsNCT05975736
Breast Cancer, Breast Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT06255808
Artificial Intelligence, Benign Breast Disease
Seoul, South Korea
View Trial Details